{"id":"W1968299608","doi":"10.1210/en.2006-1300","title":"Combination Therapy with the Advanced Glycation End Product Cross-Link Breaker, Alagebrium, and Angiotensin Converting Enzyme Inhibitors in Diabetes: Synergy or Redundancy?","year":2006,"lang":"en","type":"article","venue":"Endocrinology","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":125,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juvenile Diabetes Research Foundation","funders":"U.S. Public Health Service","keywords":"Endocrinology; Internal medicine; Advanced glycation end-product; Glycation; Diabetes mellitus; Ramipril; Albuminuria; Diabetic nephropathy; Angiotensin II; Oxidative stress; Medicine; Angiotensin-converting enzyme; Receptor; Blood pressure","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005622092,0.0003565547,0.001158345,0.000350706,0.000102982,0.0003949175,0.0004752435,0.0003818454,0.0009798831],"category_scores_gemma":[0.000164661,0.0001876023,0.0004855974,0.0002904086,0.0002826723,0.0004646681,0.0002892668,0.0007575358,0.000218805],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001274169,"about_ca_system_score_gemma":0.0002104745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001368587,"about_ca_topic_score_gemma":0.000683151,"domain_scores_codex":[0.9998367,0.00005820693,0.00001665971,0.0000215395,0.00002743638,0.00003939304],"domain_scores_gemma":[0.9998753,0.00003152632,0.00003408688,0.00001636714,0.00001209096,0.00003068988],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.03776761,0.006568289,0.008242009,0.001871998,0.001615367,0.001213169,0.0002051874,0.001684326,0.4615247,0.001479101,0.001524593,0.4763036],"study_design_scores_gemma":[0.02890441,0.3808954,0.09529629,0.000938298,0.007267132,0.009572282,0.0008052791,0.008176723,0.3921701,0.004512868,0.07118347,0.000277657],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9371803,0.0546259,0.003784518,0.0009291688,0.0002042799,0.0001280648,0.00009285009,0.00009505841,0.002959965],"genre_scores_gemma":[0.9668334,0.02367262,0.006458676,0.0005050571,0.0003567731,0.0001208259,0.0001504661,0.00001393731,0.001888358],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001158345,"threshold_uncertainty_score":0.003278017,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009028622733668319,"score_gpt":0.2702198205358457,"score_spread":0.2611911978021774,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}